Novel influenza A (H1N1) is a new flu virus of swine origin that was first detected in Mexico and the United States in March and April, 2009. The first novel H1N1 patient in the United States was confirmed by laboratory testing at CDC on April 15, 2009. The second patient was confirmed on April 17, 2009. It was quickly determined that the virus was spreading from person-to-person. On April 22, CDC activated its Emergency Operations Center to better coordinate the public health response. On April 26, 2009, the United States Government declared a public health emergency.
It’s thought that novel influenza A (H1N1) flu spreads in the same way that regular seasonal influenza viruses spread; mainly through the coughs and sneezes of people who are sick with the virus.
According to a study released August 26, 2009 by the British Medical Journal, more than half of Hong Kong's healthcare workers surveyed said they would refuse the H1N1 shot, which is not yet available, because they are afraid of side effects and doubt how safe and effective it will be. More importantly, the study suggested the trend would be repeated worldwide.
The Associated Press praised Mexico's response to the swine flu, or H1N1 outbreak, in a recent article.
Arrayit Corporation (OTCBB: ARYC), a proprietary life sciences technology leader, announces that on August 31st, 2009 the company received a patent certificate from the most populous country on the planet, the People's Republic of China. The patent covers Dr. Mark Schena's microarray methods of genotyping multiple patient samples, commonly referred to as Arrayit's "Variation Identification Platform™" (VIP) technology.
Preliminary findings in ferrets suggest that the novel 2009 H1N1 influenza virus may outcompete human seasonal influenza viruses, researchers say. Tests in animals showed that levels of the 2009 H1N1 virus rose more quickly than levels of the seasonal virus strains, and the new virus caused more severe disease. In line with previous findings by other research groups, the University of Maryland researchers also observed that the novel H1N1 virus was transmitted more easily from infected to uninfected ferrets than either of the two seasonal influenza viruses.
With an eye on convenience, cost and consumer education, SUPERVALU PHARMACIES this year has expanded its traditional flu shot offering to help ease some of the anxieties the upcoming flu season may bring.
Linkwell Corporation (OTC Bulletin Board: LWLL), a leading developer, manufacturer and distributor of healthcare-related disinfectants in China, put forward its worries about the trend of the misunderstanding concerning dealing with the spread of H1N1.
In an effort to help keep members healthy and flu-free this year, Independence Blue Cross (IBC) will offer coverage for the administration costs of the H1N1 (swine flu) vaccine when it becomes available. In addition IBC will continue to cover seasonal flu vaccine.
Health care providers may now pre-register online if they are interested in receiving pandemic H1N1 influenza vaccines and supplies when those materials become available, the Pennsylvania Department of Health said today.
Alpha Pro Tech, Ltd. (NYSE Amex: APT), a leading manufacturer of products designed to protect people, products and environments, including disposable protective apparel and building products, today announced that it will be tripling the average output of N-95 respirator masks that it has been producing since May, which will help accommodate Alpha Pro Tech’s current backlog and increase availability for the upcoming flu season/swine flu season.
The Chinese biopharmaceutical company Sinovac Biotech Ltd. on Monday announced its H1N1 (swine) flu vaccine won the approval of a panel of experts from China's State Food and Drug Administration, the Associated Press/Forbes reports. The company expects to obtain a production license later this week. According to the company, clinical trials of the H1N1 vaccine showed a single shot produced an immune response capable of protecting against H1N1 (8/31).
A laboratory study by University of Maryland researchers suggests that some of the worst fears about a virulent H1N1 pandemic flu season may not be realized this year, but does demonstrate the heightened communicability of the virus.
In response to the Centers for Disease Control and Prevention's expectation of increased cases of H1N1 flu as students return to school this fall, Colorado-based Broadnet is offering a unique package of its virtual town hall service, TeleForum, to colleges and universities in an effort to aid communication with parents, communities and students.
Rwandan President Paul Kagame at the opening of the 59th Session of the WHO Regional Committee for Africa in Kigali, Rwanda, urged delegates from across the continent to focus on promoting health, New Times/allAfrica.com reports (Nambi, 8/31).
The Department of Health and Human Services, the Department of Homeland Security, the Department of Education and Sesame Workshop, the nonprofit educational organization behind Sesame Street, have teamed up to launch a new, national public service advertising campaign designed to encourage American children and families to practice healthy habits and to take steps to prevent the spread of the 2009 H1N1 flu virus. The PSAs featured in this campaign can be viewed on www.flu.gov.
Quality Associates, Inc. (QAI) www.qualityassociatesinc.com, an established provider of services and solutions for large-scale document management, imaging, and archiving, announced the launch of its H1N1 Flu Vaccine Forms Processing Service, a comprehensive approach to help states, cities, counties, and providers in the private sector successfully and accurately capture and record essential demographic and health data from medical consent forms – a critical step in the administration of the H1N1 vaccine to millions nationwide beginning this fall.
San Diego-based MultiGEN Diagnostics Inc. has launched a novel multi-target DNA sequencing technology (MultiGEN) for a wide range of clinical testing in molecular diagnostics.
Seegene today released a new influenza A sub-type screening test, Seeplex FluA ACE Subtyping, that enables simultaneous detection of pandemic novel influenza A (H1N1), seasonal human influenza A H1, seasonal human influenza A H3 and avian influenza A H5 in a single reaction.
The Centers for Disease Control and Prevention (CDC) and the American Academy of Neurology (AAN) are requesting neurologists to report any possible new cases of Guillain-Barr- syndrome (GBS) following 2009 H1N1 flu vaccination using the CDC and U. S. Food and Drug Administration Vaccine Adverse Event Reporting System (VAERS).
A researcher from the Virginia Bioinformatics Institute (VBI) at Virginia Tech has received a grant from the National Institute of General Medical Sciences (NIGMS), part of the National Institutes of Health (NIH), to support ongoing work to develop high-performance computer models for the study of very large networks.
The number of H1N1 (swine) flu cases are steadily declining in the Southern Hemisphere as the region's flu season comes to an end, the WHO said Friday, the Associated Press reports (Engeler, 8/29).
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.